One Medical centers are now offering a "GLP-1 Management Program" for those who prefer their weight loss with a corporate seal of approval. The program treats obesity as a chronic condition for the subscription-paying class. While Walmart offers similar drugs for $149 a month, the elite are looking for "longitudinal" oversight. This is the metabolic divide in a bottle. Amazon's program integrates primary care and virtual monitoring. It is a world away from the $15 generic semaglutide versions flooding the Global South. For the American consumer, the perfect body is now a recurring monthly charge. Physical details: clear glass vials, a sleek clinical exam room, a smartphone interface. Quote: "obesity as a chronic condition."